Clinical Trial Update: Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Onreltea (brimonidine) gel in pediatric patients with capillary malformations; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Capillary Malformations

Drugs mentioned

• Onreltea (brimonidine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Capillary Malformations | Phase 3 | Status: TERMINATED